Re: Safety review: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease, Nokleby H, Aavitsland P, O'Hallahan J, Feiring B, Tilman S, Oster P. Vaccine 2007;25(16):3080-4

Vaccine

Volumn 25, Issue 39-40, 2007, Pages 6833-

  Lennon, Diana ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

BLOOD GROUP TYPING; HUMAN; IMMUNOGENICITY; LETTER; NEISSERIA MENINGITIDIS; NEISSERIACEAE INFECTION; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

BACTERIAL OUTER MEMBRANE PROTEINS; CLINICAL TRIALS AS TOPIC; HUMANS; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP B;

EID: 34548554464     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.06.024     Document Type: Letter

References (4)

1. Ameratunga S., Macmillan A., Stewart J., Scott D., Mulholland K., Crengle S., et al. Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multi-faceted strategy. Vaccine 23 17-18 (2005) 2231-2234
2. Martin D.R., Walker S.J., Baker M.G., and Lennon D. New Zealand Epidemic of Meningococcal Disease Identified by a Strain with Phenotype B:4:P1.4. J Infect Dis 177 (1998) 497-500
3. Sexton K., Lennon D., Oster P., Crengle S., Martin D., Mulholland K., et al. The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic [see comment]. NZ Med J 117 1200 (2004) U1015
4. Wong S., Lennon D., Jackson C., Stewart J., Reid S., Crengle S., et al. New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine in Children Aged 16-24 months. PIDJ 26 4 (2007) 345-350